Richard G. Wunderink
Elite in Pneumonia

Dr. Richard G. Wunderink

Pulmonary Medicine
676 N St Clair St Ste 2100, Arkes Pavilion, 
Chicago, IL 
Clinical Trials:Currently Recruiting for 1 Trial
45 Years of Experience
Elite in Pneumonia
676 N St Clair St Ste 2100, Arkes Pavilion, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Richard Wunderink is a Pulmonary Medicine provider in Chicago, Illinois. Dr. Wunderink has been practicing medicine for over 45 years and is rated as an Elite provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Pneumonia, Hospital-Acquired Pneumonia, Acute Respiratory Distress Syndrome (ARDS), Gastrostomy, and Endoscopy.

His clinical research consists of co-authoring 258 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 180 articles and participated in 3 clinical trials in the study of Pneumonia.

Graduate Institution
Indiana University School Of Medicine, 1980
Residency
Spectrum Health/Michigan State University
Specialties
Pulmonary Medicine
Licenses
Internal Medicine in IL
Board Certifications
American Board Of Internal Medicine - Critical Care Medicine (Certified)
Fellowships
Henry Ford Hospital/ Wayne State University
Hospital Affiliations
Northwestern Memorial Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

676 N St Clair St Ste 2100, Arkes Pavilion, Chicago, IL 60611

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
Enrollment Status: Recruiting
Publish Date: March 19, 2024
Intervention Type: Drug, Biological
Study Drugs: Remdesivir, Cenicriviroc, Icatibant, Pulmozyme, IC14, Celecoxib, Narsoplimab
Study Phase: Phase 2
Part 1: A Randomized Controlled Open-Label Study of CM4620 Injectable Emulsion (CM4620-IE) in Patients With Severe COVID-19 Pneumonia Part 2: A Randomized Double Blind, Placebo-Controlled Study of Auxora for the Treatment of Severe COVID-19 Pneumonia (CARDEA)
Part 1: A Randomized Controlled Open-Label Study of CM4620 Injectable Emulsion (CM4620-IE) in Patients With Severe COVID-19 Pneumonia Part 2: A Randomized Double Blind, Placebo-Controlled Study of Auxora for the Treatment of Severe COVID-19 Pneumonia (CARDEA)
Enrollment Status: Completed
Publish Date: September 18, 2025
Intervention Type: Drug
Study Drug: Auxora
Study Phase: Phase 2
A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
Enrollment Status: Terminated
Publish Date: December 09, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Multicenter, Prospective, Biomarker-result-blinded Observational Study Evaluating Immunoassay Measurements of Pancreatic Stone Protein Performed on Abionic's abioSCOPE® Device With the PSP Assay on ICU Patients at Risk of Sepsis as an Aid in Identifying Sepsis
A Multicenter, Prospective, Biomarker-result-blinded Observational Study Evaluating Immunoassay Measurements of Pancreatic Stone Protein Performed on Abionic's abioSCOPE® Device With the PSP Assay on ICU Patients at Risk of Sepsis as an Aid in Identifying Sepsis
Enrollment Status: Completed
Publish Date: January 30, 2024
Intervention Type: Device
Rapid Diagnostic Testing to Guide Antibiotic Therapy in Drug Resistant Pneumonia
Rapid Diagnostic Testing to Guide Antibiotic Therapy in Drug Resistant Pneumonia
Enrollment Status: Completed
Publish Date: February 10, 2023
Intervention Type: Other
Study Phase: Not Applicable
View 4 Less Clinical Trials

258 Total Publications

A Cornucopia of Plasma Proteomics in Moderate-Severity Community-acquired Pneumonia.
A Cornucopia of Plasma Proteomics in Moderate-Severity Community-acquired Pneumonia.
Journal: American journal of respiratory and critical care medicine
Published: September 23, 2025
Similar Doctors
Elite in Pneumonia
Dr. Mary E. Strek
Pulmonary Medicine
Elite in Pneumonia
Dr. Mary E. Strek
Pulmonary Medicine

The University Of Chicago Medical Center

5841 S Maryland Ave, 
Chicago, IL 
 (7.4 miles away)
773-702-1000
Languages Spoken:
English, French, Turkish
See accepted insurances
Accepting New Patients
Offers Telehealth

Mary Strek is a Pulmonary Medicine provider in Chicago, Illinois. Dr. Strek is rated as an Elite provider by MediFind in the treatment of Pneumonia. Her top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, and Lung Transplant. Dr. Strek is currently accepting new patients.

Benjamin D. Singer
Distinguished in Pneumonia
Dr. Benjamin D. Singer
Pulmonary Medicine
Distinguished in Pneumonia
Dr. Benjamin D. Singer
Pulmonary Medicine
676 N St Clair St Ste 2100, Arkes Pavilion, 
Chicago, IL 
 (0.1 miles away)
312-695-1800
Experience:
18+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Benjamin Singer is a Pulmonary Medicine provider in Chicago, Illinois. Dr. Singer has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Pneumonia, Acute Respiratory Distress Syndrome (ARDS), Cerebral Hypoxia, Severe Acute Respiratory Syndrome (SARS), and Lung Transplant.

Distinguished in Pneumonia
Dr. Ayodeji O. Adegunsoye
Pulmonary Medicine
Distinguished in Pneumonia
Dr. Ayodeji O. Adegunsoye
Pulmonary Medicine

The University Of Chicago

5841 S Maryland Ave, 
Chicago, IL 
 (7.4 miles away)
773-702-1000
Languages Spoken:
English, Yoruba
See accepted insurances
Accepting New Patients

Ayodeji Adegunsoye is a Pulmonary Medicine provider in Chicago, Illinois. Dr. Adegunsoye is rated as an Elite provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Hypersensitivity Pneumonitis, and Lung Transplant. Dr. Adegunsoye is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wunderink's expertise for a condition
ConditionClose
View All 8 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile